Response of Irritable Bowel Syndrome to Abdominal Fat Reduction
Irritable Bowel Syndrome, Obesity, Abdominal Obesity
About this trial
This is an interventional treatment trial for Irritable Bowel Syndrome focused on measuring Irritable Bowel Syndrome, abdominal fat, central obesity, high intensity focused ultrasound, FODMAPs diet
Eligibility Criteria
Inclusion Criteria: All patients will be 20-45 years of age. Both genders will be participated. sedentary (exercise < 2 times/week). Body mass index (BMI) will be ranged from 30 to 39.9 kg/m² and their waist circumference ≥ 102 cm for men and ≥ 88 cm for women. Patients will have the criteria of Irritable Bowel Syndrome (IBS) according to Rome IV Which are: recurrent abdominal pain on average at least one day per week during the previous three months associated with two or more of the following features must fulfill: (1) Pain is related to defecation; (2) Pain associated with a change in frequency of stool; and (3) Pain associated with a change in form or appearance of stool. mild to moderate Irritable Bowel Syndrome with score of 75- 300 according to the questionnaire of Irritable Bowel Syndrome Severity Scoring System (IBS-SSS). Exclusion Criteria: • Under 20 or above 45 years of age. Athletics Musculoskeletal, Carcinogenic, or kidney diseases, diabetes, hepatitis and cardiac disorders. Any condition that may prevent the use of the focused ultrasound on the abdominal region such as scarring, hernias or skin diseases in the abdominal area. Patients with severe Irritable Bowel Syndrome (IBS) or other known organic gastrointestinal disorders rather than IBS including: (1) Fever, Weight loss or Jaundice; (2) Change in the color of stool; (3) Signs of anemia or Thyroid disease; (4) Abdominal mass or Organomegaly; (5) Signs of intestinal obstruction.
Sites / Locations
- El-Sahel Teaching HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
study group (Group A)
control group (Group B)
Will consist of 30 cases suffering from mild to moderate Irritable Bowel Syndrome (IBS) with mild to moderate obesity will receive High Intensity Focused Ultrasound (Cavitation), a dietary regimen that combines Low Caloric Diet (LCD) and low (FODMAPs) diet and aerobic exercises with moderate intensity.
Will consist of 30 cases suffering from mild to moderate Irritable Bowel Syndrome (IBS) with mild to moderate obesity will receive only the same dietary regimen and aerobic exercise that prescribed for group A.